Home Lifestyle Elon Musk’s company, Neuralink, says it has received clearance from the US Food and Drug Administration to begin human trials

Elon Musk’s company, Neuralink, says it has received clearance from the US Food and Drug Administration to begin human trials

by admin

Neuralink has obtained authorization from the Food and Drug Administration (FDA).Food and Drug Administration) to begin its “first clinical study in a human,” the company said, a key step for Neuralink as it tries to develop a direct interface between the human brain and computers.

in communication The company said, which posted on Twitter, that the FDA’s authorization was the result of the Neuralink team working in “close cooperation with the FDA.” The company said that patient recruitment for this clinical study has not yet been opened, but it will announce more details soon.

By obtaining this authorization, Neuralink appears to have resolved the safety issues that would have led the FDA to deny its application for human trials last year. Elon Muskwho co-founded the company, responded to the announcement with a tweet Congratulations The Neuralink Team.

The Neuralink brain-computer interface uses thousands of tiny electrodes implanted in the brain to read signals from neurons and transmit them to a computer.

The timing of this statement is very much in line with Elon Musk’s remarks at a recent Neuralink event in December, where he said the company would be able to implant its first brain chip into a human within six months. During this event, Elon Musk and the Neuralink team demonstrated the use of brain chips on monkeys and pigs. During the presentation, the billionaire claimed that one of the first real applications for the chips could be restoring vision in people who have lost their sight or motor function in people with paralysis. However, the billionaire’s ultimate goal is to create brain chips that allow human intelligence to interact directly with and eventually merge with artificial intelligence.

Reuters It reported in March that the FDA had denied Neuralink’s initial application for approval. The agency has reportedly raised safety questions about brain implants, including lithium batteries and small wires that can travel to other parts of the brain, and the company’s ability to safely remove the device without harming the brain.

It is not certain that this authorization would have an impact on the federal investigation that would have opened against the company for alleged violations of the US Animal Welfare Act. The USDA Inspector General is leading the alleged investigation in response to accusations that Neuralink has killed about 1,500 animals, including nearly 300 sheep, pigs and monkeys, since 2018. Employees have claimed that the number of animals killed was too high and that they were the fruit of Elon Musk’s demands. who wanted faster results. Neuralink has denied all accusations of animal cruelty, saying the company is committed to animal welfare.

Translated article from the American magazine Forbes – Author: Siladitya Ray

<< اقرأ أيضًا: Neuralink: كيف تعمل غرسات إيلون ماسك للدماغ >>>

Related News

Leave a Comment